State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 108 actively recruiting studies with Kansas sites out of 108 registered in total. The busiest research areas in Kansas are Head and Neck Cancer, Prostate Cancer, Heart Failure. Leading sponsors running trials in the state include University of Kansas Medical Center, National Cancer Institute (NCI), Incyte Corporation. By stage, Kansas trials break down as Phase 1 (24), Phase 2 (33), Phase 3 (33), Phase 4 (3).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 108 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 108. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Head and Neck Cancer, Prostate Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT06359041 Phase 1, Phase 2
Recruiting
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participant...
Condition
Generalized Myasthenia Gravis (gMG)
Enrollment
24 pts
Location
United States
Sponsor
Cabaletta Bio
NCT07283770 Phase 1
Recruiting
Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fib...
Condition
Cystic Fibrosis
Enrollment
152 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06296394 N/A
Recruiting
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Condition
Cystic Fibrosis
Enrollment
146 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07201922 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in ...
Condition
Familial Pulmonary Fibrosis
Enrollment
80 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07559175 Phase 2
Recruiting
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult P...
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
66 pts
Location
United States, Bulgaria, Hungary
Sponsor
Aimmune Nestlé Health Science
NCT06423911 Phase 3
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Condition
Chronic Myeloid Leukemia
Enrollment
333 pts
Location
United States, Australia, Belgium
Sponsor
Ascentage Pharma Group Inc.
NCT06907199 Phase 1
Recruiting
Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Wo...
Condition
Recurrent UTIs
Enrollment
104 pts
Location
United States
Sponsor
University of Texas Southweste
NCT06640179 N/A
Recruiting
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Tr...
Condition
Kidney Transplant
Enrollment
60 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04939051 Phase 2
Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus
Condition
Barrett Esophagus
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatmen...
Condition
Early-stage Breast Cancer
Enrollment
88 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07684144 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
950 pts
Location
United States, Canada, Japan
Sponsor
Amgen
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06419374 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With...
Condition
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07093580 Phase 1
Recruiting
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Condition
Healthy Participants
Enrollment
128 pts
Location
United States
Sponsor
Shionogi
NCT06355791 N/A
Recruiting
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated Wit...
Condition
Degenerative Conditions of the Lumbar Spine
Enrollment
150 pts
Location
United States
Sponsor
Spinal Simplicity LLC
NCT07589608 Phase 2
Recruiting
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone...
Condition
Overweight
Enrollment
400 pts
Location
United States
Sponsor
Eli Lilly and Company
NCT07018323 Phase 2
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatme...
Condition
Graves' Disease
Enrollment
210 pts
Location
United States, Australia, Brazil
Sponsor
Immunovant Sciences GmbH
NCT06707493 Phase 2
Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
Condition
IDH1 Mutation
Enrollment
75 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT07020819 Phase 3
Recruiting
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as AN...
Condition
Guillain-Barre Syndrome
Enrollment
30 pts
Location
United States, Denmark, France
Sponsor
Annexon, Inc.
NCT06401421 N/A
Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Brea...
Condition
Breast Cancer
Enrollment
1,800 pts
Location
United States, Canada
Sponsor
Exact Sciences Corporation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology